Vivimed Labs Fair Value
Vivimed Labs (VIVIMEDLAB) average fair value is ₹6.83 across 2 valuation models — Price-to-Sales Valuation, Discounted Cash Flow (DCF), vs a current market price of ₹7.63 (-10.42%), fair value range ₹1.52–₹12.15. For live price and a broader fundamental view, visit Vivimed Labs share price screener.
Fair Value Analysis Export
VIVIMEDLAB Fair Value vs Current Price — Valuation Summary
VIVIMEDLAB average fair value, fair value range, price gap and valuation status across 2 models: Price-to-Sales Valuation, Discounted Cash Flow (DCF). See VIVIMEDLAB P/B ratio history to compare market price against book value per share.
Price-to-Sales Valuation
Discounted Cash Flow (DCF)
VIVIMEDLAB Fair Value Analysis — Data Sources & Coverage
Vivimed Labs financial data sources, valuation methods applied and sector benchmarks used — 2025 financial year. Examine VIVIMEDLAB earnings for recent quarterly revenue, profit and EPS trends.
Available Data Sources: Financial statements, balance sheet data , sector comparisons.
Data Currency: Financial data is from the previous year (2025).
VIVIMEDLAB vs Healthcare Sector Peers — P/E, P/B & Market Cap
Vivimed Labs P/E ratio, P/B ratio and market capitalisation vs Healthcare sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Jeena Sikho Lifecare | JSLL | 34.16 | 16.25 | ₹7,383 |
| Murae Organisor | MURAE | 2.86 | 0.2 | ₹41 |
| Sun Pharmaceutical | SUNPHARMA | 38.3 | 5.27 | ₹441,070 |
| KRM Ayurveda | KRMAYURVED | - | 4.4 | ₹532 |
| Sat Kartar Life | SATKARTAR | 14.29 | 3.61 | ₹252 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.